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the elderly and is strongly associated with comorbid conditions such as atheroscle-
rosis	or	diabetes,	which	are	pathologically	characterized	by	 increased	 inflammation	





neuronal damage and motor deficits specifically in aged mice. This is associated with 
increased	levels	of	plasma	proinflammatory	cytokines,	rather	than	with	an	increase	of	
inflammatory	mediators	 in	the	affected	brain	parenchyma.	Nascent	transcriptomics	
data	with	mature	microRNA	sequencing	were	used	 to	 identify	 the	neuron-specific	
miRNome,	 in	order	to	decipher	dysregulated	miRNAs	 in	the	brains	of	aged	animals	
with	 stroke	and	co-existing	 inflammation.	We	pinpoint	 a	previously	uninvestigated	
miRNA	in	the	brain,	miR-127,	that	is	highly	neuronal,	to	be	associated	with	increased	
cell	death	 in	 the	aged,	LPS-injected	 ischemic	mice.	Target	prediction	 tools	 indicate	
that	miR-127	interacts	with	several	basally	expressed	neuronal	genes,	and	of	these	we	
verify miR-127 binding to Psmd3.	Finally,	we	report	reduced	expression	of	miR-127	in	
human	stroke	brains.	Our	results	underline	the	impact	of	peripheral	inflammation	on	
the outcome of stroke in aged subjects and pinpoint molecular targets for restoring 
endogenous neuronal capacity to combat ischemic stroke.
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1  |  INTRODUC TION
Stroke	is	the	third	leading	cause	of	death	in	the	Western	countries	
(Wang	et	al.,	2016).	Despite	extensive	research,	novel	neuroprotec-
tive treatment paradigms showing promise in preclinical settings 
have	 consistently	 failed	 in	 clinical	 trials,	 suggesting	 the	 inability	
of preclinical models to mimic human disease. Men seem to be at 
higher	 risk	of	developing	 stroke	until	 the	age	of	75	years,	but	 the	
overall stroke incidence is still higher among women due to their 
increased	 life	 expectancy	 (Keteepe-Arachi	 &Sharma,	 2017).	 This	
poses a major hurdle in preclinical stroke research: although most 
of the stroke patients are elderly females with a variable medical 
background,	 the	majority	of	 the	preclinical	studies	are	still	 carried	
out	using	healthy,	young	males.
The common comorbidities affecting the stroke patients include 
atherosclerosis,	different	types	of	infections,	and	diabetes,	all	entail-
ing	peripheral	inflammation.	We	together	with	others	have	shown	that	




low level of peripheral inflammation present in various comorbid con-
ditions,	aggravates	ischemia-induced	cell	death	(McColl	et	al.,	2007)	





ischemic vulnerability in this context have not been elucidated.
MiRNAs	 are	 single-stranded,	 non-coding	 molecules	 consisting	
of	18–25	nucleotides,	which	control	gene	expression	by	either	pro-
moting	 the	degradation	of	messenger-RNAs	 (mRNAs)	or	 inhibiting	
their	 translation,	 although	 they	also	may	have	binding	 sites	at	 the	
promoter	 regions	 of	 genes	 (Place	 et	 al.,	 2008).	 Growing	 evidence	
suggests	miRNAs	as	important	regulators	of	cellular	survival	in	isch-
emic	stroke,	yet	it	is	completely	unknown	how	miRNA	regulation	is	
altered when comorbidities are present.
Here	 we	 integrate	 nascent	 transcriptomics	 data	 (GRO-seq)	
with	 small	 RNA-sequencing	 to	 identify	 mature	 miRNA	 deregu-
lation	 among	 the	 neuron-specific	miRNome	 and	 to	 evaluate	 the	
impact	 of	 aging-associated	 perturbation	 on	 mature	 miRNA	 ex-
pression.	 We	 pinpoint	 miR-127-5p	 downregulation	 and	 associa-
tion with decreased neuronal survival in a mouse model of stroke 
comprising aging and peripheral inflammation. Target prediction 
tools for human and mouse indicate that both miR-127-3p and 
miR-127-5p	have	several	putative	targets	related	to	apoptosis.	We	
verify	26S	proteasome	non-ATPase	regulatory	subunit	3	 (Psmd3)	
to be a target for mouse miR-127-5p. The increased neuronal vul-
nerability in aged mice subjected to peripheral inflammation led 
to	 impaired	motor	 functions	 and	 importantly,	we	 show	 that	 the	




2.1  |  Aged mice subjected to peripheral 
inflammation showed significantly increased lesion 
size and aggravated ischemia-induced deficits in 
sensory and motor functions
To	 mimic	 comorbidity-related	 peripheral	 inflammation,	 young	
and aged mice were subjected to intraperitoneal injection of 
LPS	30	min	prior	 to	permanent	middle	 cerebral	 artery	occlusion	
(pMCAO).	Quantification	of	 the	MRI	 images	 at	 24	h	 post-stroke	
revealed significantly increased cell death specifically in aged 
mice	 subjected	 to	 LPS	 compared	 to	 any	 other	 treatment	 group	
(Figure	1a–e).	Physiological	parameters	did	not	differ	between	the	
groups	(data	not	shown).
Whereas	 LPS	 in	 young	 animals	 failed	 to	 aggravate	 the	 motor	
deficits,	 aged	 animals	 were	 significantly	 more	 vulnerable	 to	
stroke-induced deficits in the sensory and motor coordination as 
measured	 by	 Latency	 to	 move	 (Figure	 1f)	 and	 Adhesive	 removal	
tests	(Figure	1g,h).	Adhesive	removal	test	revealed	that	aged,	LPS-
treated animals were significantly slower in sensing the adhesive 
batch	compared	to	any	other	groups	(Figure	1g).	 In	addition,	aged,	
LPS-treated	mice	showed	a	clear	impairment	in	their	ability	to	sense	
the adhesive batch in the contralateral paw compared to the ipsilat-
eral paw. This deficit in sensing was not evident in any other study 
groups	 (Figure	 1g).	However,	 LPS-induced	 reduction	 in	 the	 speed	
of the removal of the adhesive from the contralateral paw in young 
mice and this deficit was significant also in aged vehicle-treated 
animals	(Figure	1h).	There	were	no	differences	between	any	of	the	
treatment groups in the time it took for the mice to remove the ad-
hesive	batches	from	the	contralateral	side.	Instead,	the	LPS-treated	
aged mice were impaired also in their ability to remove the batch 
from	ipsilateral	paw,	suggesting	an	overall	impairment	in	the	motor	
function of the mice.
2.2  |  Proinflammatory cytokines were elevated 
in the peri-ischemic area of aged mice, and in 
plasma of the aged, LPS-treated mice
qPCR	 revealed	 a	 significant	 age-dependent	 increase	 in	 the	mRNA	
levels of proinflammatory cytokines IL-1β,	IL-6,	and	TNFα in the peri-




did not further alter the expression levels of these genes.
The	levels	of	proinflammatory	cytokine	IFNγ were significantly 
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2.3  |  Peripheral inflammation increased microglial 
activation in the young mouse brains and induced 
neutrophil infiltration regardless of age, but failed to 
affect astrocytic activation, which was aggravated by 
age alone
As	 expected,	 LPS-induced	 peripheral	 inflammation	 increased	 the	
expression	of	 ionizing	calcium-binding	adaptor	molecule	1	(Iba1),	a	
marker	 for	 activated	microglia/macrophages,	 in	 the	PI-area	 of	 the	
ischemic young mice compared to their vehicle-treated controls 










activity	 in	 the	 PI-area	 compared	 to	 young	 vehicle	 or	 LPS-treated	
mice	at	24	h	after	stroke	(Figure	S3a–e).















adjusted p	=	0.0023	n	=	5–8	(f)	F(1,	16)	=	8.54	p	=	0.010	interaction	effect;	F(1,	16)	=	66.03	p < 0.0001 age effect; F(1,	16)	=	10.28	p	=	0.0055	
treatment	effect	of	two-way	ANOVA	followed	by	Tukey's	multiple	comparisons	test,	adjusted	p	=	0.004	n	=	4–5	(g)	F(3,	34)	=	13.63	
p < 0.0001 age effect; F(1,	34)	=	6.66	p	=	0.014	treatment	effect	of	two-way	ANOVA	followed	by	Tukey's	multiple	comparisons	test,	
adjusted p	=	0.0388*	p	=	0.0015**	p	=	0.0002***	n	=	5–6	(h)	F(3,	34)	=	10.68	p < 0.0001 age effect; F(1,	34)	=	18.46	p	=	0.0001	treatment	
effect	of	two-way	ANOVA	followed	by	Tukey's	multiple	comparisons	test,	adjusted	p	=	0.030	in	young	LPS	ipsi	vs.	contra,	p	=	0.0044	in	aged	
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2.4  |  The levels of miR-127 were deregulated 
in the brains of aged, ischemic mice suffering from 
peripheral inflammation
MiRNA	 sequencing	 was	 carried	 out	 to	 reveal	 the	miRNA	 expres-
sion	profile	in	the	PI-area,	and	to	uncover	possible	mediators	for	the	
increased vulnerability to the ischemic brain damage in aged mice 
subjected	to	peripheral	inflammation	(Figure	3a).	Stringent	factorial	
statistical analysis fitting a four-factor combination model resulted 
in	22	miRNAs	being	differentially	 regulated	 in	 the	aged	mice	 sub-





ing that more than natural changes in the miRnome were captured 
and possibly caused by a combinatorial effect of aging and inflam-
mation.	However,	the	expression	levels	of	miRNAs	from	the	PI	area	
are resulting from several cell types harvested in vivo. The high vari-
ation among the expression levels between different cell types and 




To assess the tissue specificity of the differentially expressed 
miRNAs	 we	 looked	 at	 the	 primary	 miRNA	 transcription	 levels	 in	
seven mouse cell types to identify those specifically expressed in 
neurons.	 We	 generated	 GRO-seq	 expression	 profiles	 for	 mouse	
primary	neurons	and	microglia	and	assembled	existing	public	GRO-
seq	data	for	five	other	cell	types	including	muscle	cells,	embryonic	
stem	 cells,	macrophages,	 adipocyctes,	 and	 fibroblasts.	 Essentially,	
GRO-seq	 identified	255	neuron-expressed	miRNA	loci	 (Figure	3b),	




other	 cell	 types	 than	 neurons,	 11	 neuron-specific	 miRNAs	 were	
chosen	 for	 further	 analysis	based	on	GRO-seq	expression.	Of	 the	
resulting	11	miRNAs,	5	were	selected	for	validation	by	qPCR,	based	
on	abundance	of	their	expression	(data	not	shown).













































































































































10 *** p = 0.0002
R 2 0.4863















    |  5 of 13LOPPI et aL.
From	the	set	of	validated	genes,	we	were	able	to	demonstrate	
that the level of miR-127-5p was significantly downregulated in 
the	 PI	 area	 of	 aged	 mice	 subjected	 to	 peripheral	 inflammation,	
when	 compared	 to	 their	 age-matched,	 vehicle-treated	 controls	
(Figure	 3c).	 This	 was	 confirmed	 by	 in situ	 hybridization	 of	 miR-




pression	 of	 miR-127	 is	 altered	 in	 human	 stroke.	 Indeed,	 miRNA	
analysis of post-mortem human brain showed a similar downregula-
tion	in	the	levels	of	miR-127	(both	3p-	and	5p-arms)	in	the	ischemic	
hemisphere compared to the unaffected contralateral hemisphere 
(Figure	3h).	The	expression	 level	of	miR-127-5p	was	also	reduced	
upon	 glutamate	 exposure	 in	 primary	 cortical	 neurons,	mimicking	
excitotoxic	 insult	 caused	 by	 stroke,	 compared	 to	 vehicle-treated	
control	cells	(Figure	3i).
2.5  |  MiR-127-5p targets the expression 
level of Psmd3
In	 order	 to	 reveal	 targets	 for	 miR-127,	 we	 took	 advantage	 of	 the	
TargetScan	 prediction	 tool	 and	 retrieved	 the	 predicted	 targets	 of	
mouse	mir-127	(5p-arm)	and	human	miR-127	(both	3p	and	5p	arms)	
(Figure	 4a).	 All	 the	 subsequent	 analysis	 were	 performed	 using	 R/
Bioconductor	(version	3.5.0).	We	used	the	package	“STRINGdb”	that	
provides	an	interface	to	the	STRING	protein–protein	interaction	da-
tabase.	 Protein–protein	 interaction	 (PPI)	 networks	 of	 the	 predicted	
targets were built taking into account only the interactions with the 





Next,	we	used	overlap coefficient to compare the pairs of Mus musculus 
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and Homo sapiens clusters and to find the best candidate pairs in terms 
of	pathway	similarity.	For	this	analysis,	only	clusters	with	more	than	
15	genes	were	taken	into	account.	Among	the	top	three	couples,	we	






in	 human	 and	mouse	 clusters,	 the	 genes	Psmd4,	Btrc,	 Skp2,	Cdc27,	
and Psmb11,	all	involved	in	ubiquitin-proteasome	system	in	one	way	
or	another,	are	connected	with	proteasome	genes	PSMB5 and Psmd3 
(Figure	4e,f).	Since	the	proteasomes	are	known	to	be	connected	with	
inflammation,	 apoptotic	 processes,	 and	 caspase	 activity,	 they	were	
chosen	to	further	analysis.	(See	Appendix	S1	for	details.)
The pulldown assay revealed that miR-127-5p was bound to 
Psmd3	 (Figure	 5a),	 which	 was	 confirmed	 with	 luciferase	 assay	
(Figure	 5b).	 Since	 the	 3′UTR	 of	 PSMB5	 lacks	 clear	 binding	 site	
for	miR-127-5p,	 we	were	 unable	 to	 verify	 the	 binding	with	 these	
methods.	To	evaluate	 the	expression	 levels	of	Psmd3	and	PSMB5	
in	 the	 peri-ischemic	 samples,	 we	 carried	 out	Western	 blotting	 to	
see whether their protein levels were altered in ischemic stroke in 
mice.	Quantification	of	the	Western	blot	showed	that	while	Psmd3	
remained	 unchanged	 (Figure	 5c),	 the	 protein	 level	 of	 PSMB5	was	
significantly elevated in the peri-ischemic area of the aged mice 
subjected to peripheral inflammation compared to the same area of 
their	age-matched,	vehicle-treated	controls	 (Figure	5f,g).	Next,	the	




levels of Psmd3 and PSMB5	in	N2a	cells	overexpressing	miR-127-5p.	
To	 our	 surprise,	 Psmd3	 was	 again	 unchanged	 (Figure	 5e),	 while	
PSMB5	was	significantly	decreased	in	N2a	cells	transfected	with	mir-
127	mimic	when	compared	to	mock-transfected	cells	(Figure	5j).
2.6  |  Significant alterations were observed in 
caspase-3 immunoreactivity, along with apoptosis and 
proteasome activity
To further evaluate the importance of apoptosis in the increased 
vulnerability	 of	 the	 aged	 mice	 predisposed	 to	 peripheral	 LPS-
induced	inflammation,	we	carried	out	immunostaining	against	cas-
pase-3.	Specifically,	aged	mice	subjected	to	peripheral	LPS-induced	






transfected	 cells,	while	 in	miR-127	overexpressing	 cells	 it	 stayed	
on	normoxic	level.	After	this,	we	used	similarly	transfected	and	ex-
posed	cells	to	assess	proteasome	activity	after	hypoxia,	expecting	
F I G U R E  4 Pathway	analysis	of	very	connected	targets	of	miR-127	between	human	and	mouse	revealed	proteasomes	Psmd3 and PSMB5. 
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it	 to	 be	 lower	 in	 cells	 overexpressing	 miR-127,	 according	 to	 our	
finding	 showing	 decreased	 PSMB5	 level	 in	 miR-127	 transfected	
cells	(Figure	5h).	PSMB5	protein	is	also	known	as	20S	proteasome	
subunit β5,	 containing	 chymotrypsin-like	 activity	 (Coux,	 1996).	
Contrary	 to	 our	 expectations,	 chymotrypsin-like	 proteasome	 ac-
tivity was markedly increased along with miR-127 overexpression 
in	hypoxic	cells	(Figure	6h).
3  |  DISCUSSION
The heterogeneity of stroke-induced effects in patients causes a 
main	 hurdle	 in	 efficient	 drug	 discovery	 for	 ischemic	 stroke.	Not	
only	 are	most	 of	 the	 patients	 elderly,	 but	 also	 affected	 by	mul-
tiple	conditions	 influencing	the	peripheral	 immune	system,	caus-
ing the immune cells to prime themselves toward an inflammatory 
state.	In	clinical	trials	these	priming	conditions	cause	unexpected	
responses,	 thereby	 influencing	 the	 pathways	 targeted	 by	 the	
novel therapeutics. This possibly explains the failure to trans-
late	the	preclinical	findings	to	efficient	therapeutics.	It	 is	thus	of	
high importance to conduct studies assessing the contribution of 






ing decreased neuroregeneration and impaired brain repairment via 
reduced	myelination,	since	neuregulin	is	shown	to	have	a	significant	
effect	 on	 myelinating	 oligodendrocytes	 (Lundgaard	 et	 al.,	 2013;	
Wang	et	al.,	2007).	Higher	levels	of	proinflammatory	gene	products	
implying	 increased	 inflammation	were	 as	well	 observed	 in	 the	 PI-
area of the aged mice. This is in line with a previous study showing 
increased	brain	levels	of	TNFα	after	injury	in	aged	animals	(Le	et	al.,	
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2014),	 although	 also	 contradictory	 findings	 have	 been	 reported	
(Sieber	 et	 al.,	 2011).	 Importantly,	 aging	 has	 been	 shown	 to	 prime	
cells of the peripheral immune system both in humans and in ani-
mals,	demonstrated	as	increased	levels	of	plasma	TNFα along with 
activated	 macrophages	 (Pizza	 et	 al.,	 2011;	 Salminen	 et	 al.,	 2011).	
Moreover,	 hypercholesterolemic	 mice	 show	 elevated	 ischemia-in-
duced	plasma	 levels	 of	 TNFα and worsened outcome after stroke 
(Herz	et	al.,	2014).	Our	data	of	the	increased	levels	of	IFNγ	and	TNFα 
in	 the	 plasma	 specifically	 in	 the	 aged,	 LPS-treated	mice	with	 cor-
relation	to	the	lesion	size	may	thus	have	clinical	relevance	as	stroke	
patients	have	increased	plasma	levels	of	TNFα,	which	are	correlated	
with	 the	 infarct	 volume	 (Martínez-Sánchez,	 2014).	 Indeed,	 inflam-
matory markers have diagnostic value as predictors of the severity 
of	the	outcome	of	stroke	(Bokhari	et	al.,	2014).
Respiratory	tract	infections,	among	others,	are	not	only	associ-
ated	with	 increased	 risk	of	 ischemic	events,	but	 infections	 shortly	
preceding	 the	 ischemic	 stroke	 also	worsen	 the	 outcome	 (Grabska	
et	al.,	2011).	However,	 the	number	of	preclinical	 studies	assessing	
the effect of pre-ischemic inflammatory conditions on the outcome 
of	 stroke	 is	 limited.	 Low	 dose	 of	 peripheral	 LPS	 aggravates	 isch-
emia-induced neuronal death in a transient mouse model of cerebral 
stroke	(McColl	et	al.,	2007),	impairs	motor	functions,	and	increases	
BBB	permeability	(Doll	et	al.,	2015).	In	line	with	these	findings,	we	
have previously reported that aged mice subjected to low-grade pe-
ripheral infection induced by Trichuris Muris parasite administration 
show	aggravated	neuronal	death	upon	 ischemic	stroke	 (Dhungana	
et	 al.,	 2013).	Here	we	extent	 these	 findings	using	LPS	as	 a	model	
of peripheral inflammation to report also impairments in motor 








n	=	6–8	(f)	F(1,	20)	=	111.8	p < 0.0001 interaction effect; F(1,	20)	=	111.5	p	<	0.0001	hypoxia	and	treatment	effect	of	two-way	ANOVA	
followed	by	Tukey's	multiple	comparisons	test,	adjusted	p < 0.0001 n	=	6	(g)	F(1,	20)	=	25.11	p < 0.0001 interaction effect; F(1,	20)	=	56.45	
p < 0.0001 hypoxia effect; F(1,	20)	=	24.9	p	<	0.0001	treatment	effect	of	two-way	ANOVA	followed	by	Tukey's	multiple	comparisons	test,	






















































































to	 see	 that	 LPS-induced	 a	massive	 neutrophil	 infiltration	 into	 the	
ischemic core regardless of age with no correlation with extent of 
neuronal	death.	The	 increased	 lesion	size	was	not	associated	with	
altered brain inflammatory response which is surprising since as-
trocytes and microglia possess significant roles in the post-ischemic 
cascade of events—either detrimental or beneficial. These differ-
ences are likely to be explained by the different model for induc-
ing	 the	 peripheral	 inflammation.	 In	 addition,	 the	 stroke	 pathology	
is significantly different between the transient and the permanent 
models,	 highlighting	 the	 importance	 of	 investigating	 pathological	
mechanisms across different models and conditions.
To discover the molecular mediators underlying the increased 
neuronal	 vulnerability	 in	 aged,	 LPS-treated	 mice,	 we	 integrated	




producing	 primary	 miRNA	 transcripts	 in	 primary	 neurons.	 These	
data	 were	 then	 used	 to	 extract	 top	 candidates	 from	miRNA-seq,	
which	was	 obtained	 from	 the	PI	 site	 of	 the	 brain	 post-stroke	 and	
thus	 contained	 every	 brain	 cell	 type.	 From	 the	 top	 3	miRNA	 loci	
highly	expressed	 in	neurons,	we	further	 focused	on	miR-127	from	
Cluster	1.	The	other	two	loci	were	mmu-miR-335,	and	Cluster	2	har-
boring miR-129 family precursors. MiR-129 has been identified in 
mouse	brain	tissue	(Lagos-Quintana,	2002),	yet	it	was	not	found	to	
be	significantly	altered	 in	 the	miRNA-seq	analysis.	Although	 there	
is	 no	 GRO-seq	 data	 available	 for	 mouse	 astrocytes	 or	 oligoden-
drocytes,	existing	reports	show	that	mmu-miR-335	is	expressed	in	
astrocytes	and	 implicated	 in	astrocytoma	development	 (Shu	et	al.,	
2011).	This	 suggested	 that	astrocytes	could	also	have	contributed	
to	 the	miR-335	 expression	 profile	 in	 the	miRNA-seq	 dataset.	We	
carried	out	qPCR	measurements	for	miR-127	in	cultured	mouse	pri-
mary	astrocytes	and	microglia,	and	failed	to	detect	miR-127	in	these	
cell	 types	 (data	 not	 shown).	Our	 data	 showing	 downregulation	 of	
miR-127-5p in the brains of aged mice suffering from stroke and pe-
ripheral	inflammation,	and	our	GRO-seq	complemented	with	qPCR	
data on primary cell cultures suggest it to be very neuron specific in 
mice.	The	reduction	in	the	levels	of	miR-127	is	also	clinically	relevant,	
as both miR-127-3p and miR-127-5p were significantly downregu-
lated	in	human	stroke	brain	samples.	However,	in	humans	the	neu-
ron	 specificity	 cannot	 be	 confirmed,	 since	miR-127-3p	 expression	





aggravate the lesion formation by turning into glial scar in the acute 
phase	 (McKeon	et	al.,	1991).	Oligodendrocytes	are	more	 sensitive	
to	deprivation	of	oxygen	and	nutrients	than	other	glia	(Giacci	et	al.,	
2018),	 and	 death	 of	 oligodendrocytes	 leads	 to	 demyelination	 and	
axonal	degeneration,	making	all	matters	worse.	Because	of	this,	ef-
fects of miR-127 in especially human oligodendrocytes and glial cells 
need	further	clarification.	Until	now,	miR-127	has	been	shown	to	be	
beneficial	in	human	keratocytes	upon	LPS	exposure	(Li	et	al.,	2018)	
and miR-127-3p has been suggested as a biomarker for frontotem-
poral	dementia	(Piscopo	et	al.,	2018),	yet	nothing	is	known	about	the	
function of miR-127 in the brain during hypoxic and inflammatory 
conditions.
To	evaluate	 the	pathways	 targeted	by	miR-127,	we	carried	out	
pathway analysis of the predicted targets for both arms for human 
and	5p-arm	for	mouse,	and	pinpointed	proteasome	Psmd3 as a tar-
get	for	miR-127-5p.	Proteasome	dysfunction	is	evidently	connected	
with	apoptosis	(Low,	2006),	which	is	a	central	feature	in	stroke-in-




activity is known to markedly alter expression of genes having an 
important	role	 in	aging	and	neurodegeneration	 (Ding	et	al.,	2004),	
for example increasing neuronal pentraxin 1 which is mediating brain 




bition of proteasome activity has been stated to promote apoptosis 
(Qiu	 et	 al.,	 2000).	On	 the	 other	 hand,	 proteasome	 activity	 inhibi-
tion	has	as	well	 reported	to	have	anti-inflammatory	effects	 (Meng	
et	al.,	1999)	and	 it	 is	estimated	to	be	beneficial	 in	 ischemic	stroke	
(Di	Napoli,	2003).	Proteasomal	activation	may	also	aid	cell	survival	






parts	 and	one	20S	 core	 (Tanaka,	 2009).	 Psmd3	 is	 part	 of	 the	19S	
unit,	whereas	20S	core	accommodates	PSMB5.	Proteolytic	activity	
of	26S	proteasome	 is	 impaired	during	 ischemia	due	 to	ATP	deple-
tion,	 which	 causes	 inactivation	 of	 the	 19S	 unit,	 leaving	 only	 20S	
core	functional	under	oxidative	stress	(Reinheckel	et	al.,	1998).	This	
may	explain	our	findings	showing	miR-127	targeting	Psmd3,	but	the	
levels of which being inconsistent with the expression of miR-127. 
Despite	of	PSMB5	 lacking	 the	known	binding	site	 for	miR-127-5p,	
we	detected	downregulation	of	PSMB5	in	miR-127	overexpressing	
cells	but	upregulation	 in	20S	activity	 in	 the	same	cells,	which	may	
as	well	be	due	to	disassembly	of	the	26S	proteasome,	and/or	pos-
sible compensatory mechanisms due to miR-127 overexpression. 
Overexpression	may	cause	unspecific	binding	to	PSMB5,	but	there	
may	 as	well	 be	 currently	 unknown	mechanisms	of	miRNA	actions	
behind	our	results.	Within	this	study,	we	were	unable	to	clarify	this,	
but this issue indeed deserves further attention.
It	 is	 plausible	 that	 neuroprotective	 effect	 of	miR-127	 is	me-
diated	 through	 nuclear	 factor-kappa	 B	 (Nf-κB):	 20S	 proteasome	
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targets	 phosphorylated	 I-κB	 and	 degrades	 it,	 which	 activates	
Nf-κB	(Carroll	et	al.,	2000).	Although	Nf-κB	activation	in	glial	cells	
is	known	to	have	detrimental	consequences	 (Saggu	et	al.,	2016),	
in neurons it is involved in synaptic plasticity and neuronal sur-
vival,	and	it	is	triggering	an	endogenous	caspase	inhibitory	system	
(Mattson,	2005).	This	is	in	line	with	our	in	vivo	findings	and	as	well	
with in vitro results showing decreased apoptosis and increased 
20S	activity.
In	 conclusion,	 here	 we	 integrate	 GRO-seq	 data	 with	 mature	
miRNA	sequencing	to	identify	the	neuron-specific	miRNome	and	
pinpoint	a	previously	uninvestigated	miRNA	in	the	brain,	miR-127,	
that was highly expressed in neurons and was associated with in-
creased	 cell	 death	 in	 the	 aged,	 LPS-injected	 ischemic	 mice.	We	
demonstrated that miR-127-5p interacts with Psmd3,	 and	has	an	
effect on cellular apoptosis and proteasomal activity in in vitro 
conditions mimicking ischemic neuronal damage. To provide clin-
ical	relevance	for	our	findings,	we	also	reported	that	the	levels	of	
miR-127	are	similarly	decreased	in	human	stroke	brains.	Although	
it is likely that targeting miR-127 is not effective in preventing 
stroke-induced	neuronal	death	 in	young	animals,	our	 results	un-
derline the impact of peripheral inflammation on the outcome 
stroke in aging and pinpoint molecular targets for restoring endog-
enous neuronal capacity to combat ischemic stroke specifically in 
aged subjects.





old)	 C57Bl/6	 J	 mice	 were	 used	 for	 the	 study.	 25%	 of	 the	 mice	
were	females,	and	they	were	divided	equally	to	treatment	groups	
(young	 vehicle,	 young	 LPS,	 aged	 vehicle,	 and	 aged	 LPS	 treated).	
The	results	of	the	females	did	not	differ	from	the	males,	so	they	
are not separated in the analysis. The mice were housed individu-
ally	in	controlled	temperature,	humidity,	and	light	conditions	(12	h	
light/dark	cycles).	Water	and	food	were	provided	ad	libitum.	The	
randomization	 into	 treatment	groups	was	done	according	 to	 the	
RIGOR	 criteria	 by	 using	 GraphPad	 QuickCalcs	 software	 (www.
graph	pad.com/quick	calcs/,	 GraphPad	 Software,	 San	 Diego,	 CA,	
USA)	and	all	analyses	were	performed	blinded	to	the	study	groups.	
The	exclusion	 criteria	were	pre-set:	 hemorrhages	visible	 in	MRI,	






Animal	 Experiment	 Board	 of	 Finland	 and	 the	 Council	 of	 Europe	
Legislation	and	Regulation	for	Animal	Protection	guidelines	for	the	
care and use of animals were followed.




















4.4  |  In vitro experiments
Primary	 cortical	 neuron	 cultures	were	used	 for	 glutamate	expo-




were	 transfected	with	miR-127	mimics	 and	 exposed	 to	 hypoxia,	
and	the	samples	were	used	to	evaluate	apoptotic	activity,	protea-
somal	activity,	and	levels	of	Psmd3	and	PSMB5.	MiRNA	pulldown	
assay and luciferase assay to verify targets of miR-127 was as well 
conducted with these cells.
4.5  |  Human brain samples
Brain	samples	from	6	patients	who	died	from	an	ischemic	stroke	
were	 included	 in	 this	 study	 (Table	 1).	 Briefly,	 post-mortem	 tis-
sue	samples	 from	the	 infarct	core	 (IC)	and	 the	contralateral	 (CL)	
areas	were	collected,	preserved	 immediately	by	snap	 freezing	 in	
liquid	nitrogen,	and	stored	at	−80°C	until	 further	use.	All	proce-
dures performed in this study were in accordance with the ethical 
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standards	of	the	Ethics	Committee	of	the	Vall	d’Hebron	Hospital	
(PR[HG]85/04)	and	informed	consent	was	obtained	from	relatives	







The statistical tests used are indicated in each figure legend. p-val-
ues < 0.05 were considered as significant. The data are presented as 
mean	±	standard	deviation,	and	equality	of	mean	and	median	values	in	
representing the data has been confirmed for each dataset.
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